JACQUES JM
VAN DONGEN
Investigador
Hannover Medical School
Hanóver, AlemaniaPublicaciones en colaboración con investigadores/as de Hannover Medical School (18)
2020
-
Successful Preclinical Development of Gene Therapy for Recombinase-Activating Gene-1-Deficient SCID
Molecular Therapy - Methods and Clinical Development, Vol. 17, pp. 666-682
2014
-
Successful RAG1-SCID gene therapy depends on the level of RAG1 expression
Journal of Allergy and Clinical Immunology
-
T-cell receptor Vβ skewing frequently occurs in refractory cytopenia of childhood and is associated with an expansion of effector cytotoxic T cells: A prospective study by EWOG-MDS
Blood Cancer Journal, Vol. 4, Núm. 5
-
The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood: A prospective study by EWOG-MDS
Leukemia
2013
-
The MLL recombinome of acute leukemias in 2013
Leukemia, Vol. 27, Núm. 11, pp. 2165-2176
2011
-
Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer
Leukemia, Vol. 25, Núm. 9, pp. 1471-1483
-
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: Results of the AIEOP-BFM-ALL 2000 study
Blood, Vol. 118, Núm. 8, pp. 2077-2084
2010
-
Correction of B-cell development in Btk-deficient mice using lentiviral vectors with codon-optimized human BTK
Leukemia, Vol. 24, Núm. 9, pp. 1617-1630
-
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: Results in 3184 patients of the AIEOP-BFMALL 2000 study
Blood, Vol. 115, Núm. 16, pp. 3206-3214
2009
-
New insights to the MLL recombinome of acute leukemias
Leukemia, Vol. 23, Núm. 8, pp. 1490-1499
2008
2006
-
Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networks
Leukemia, Vol. 20, Núm. 8, pp. 1385-1392
-
The MLL recombinome of acute leukemias
Leukemia, Vol. 20, Núm. 5, pp. 777-784
2005
-
Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection
Clinical Cancer Research, Vol. 11, Núm. 21, pp. 7720-7727
2004
-
High incidence and unique features of antigen receptor gene rearrangements in TEL-AML1-positive leukemias
Leukemia, Vol. 18, Núm. 1, pp. 84-91
2002
-
Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL
Blood, Vol. 99, Núm. 12, pp. 4386-4393
1998
-
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
Lancet, Vol. 352, Núm. 9142, pp. 1731-1738
1990
-
Possibilities and limitations of immunological marker analyses for the detection of minimal residual disease in childhood acute lymphoblastic leukemia
Oncology Research and Treatment, Vol. 13, Núm. 3, pp. 166-174